Zobrazeno 1 - 10
of 141
pro vyhledávání: '"Sun H, Kim"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Aromatase inhibitors (AIs) are a cornerstone adjuvant treatment of many hormone receptor-positive breast cancers, and nearly half of women taking aromatase inhibitors suffer from AI-induced arthralgia (AIA), also known as AI-associated musculoskeleta
Externí odkaz:
https://doaj.org/article/e1dbfdd7c04d43d89884f77b9f50b517
Autor:
Sangeeta R. Kashyap, Cyrus Desouza, Vanita R. Aroda, Sun H. Kim, Lisa M. Neff, Shannon S. Wu, Philip Raskin, Richard Pratley
Publikováno v:
American Journal of Preventive Cardiology, Vol 15, Iss , Pp 100525- (2023)
Objectives: Prediabetes represents a spectrum of metabolic abnormalities, including insulin resistance and secretory impairment, that carries increased cardiovascular disease (CVD) risk. It is unclear whether specific glycemic and metabolic sub-class
Externí odkaz:
https://doaj.org/article/f5ed81aad79c485488993c6bb0d8a7a8
Autor:
Jin-Seok Kim, Seon Won Kim, Jong Seok Lee, Seung Ku Lee, Robert Abbott, Ki Yeol Lee, Hong Euy Lim, Ki-Chul Sung, Goo-Yeong Cho, Kwang Kon Koh, Sun H. Kim, Chol Shin, Seong Hwan Kim
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-9 (2021)
Abstract Background The independent role of pericardial adipose tissue (PAT) as an ectopic fat associated with cardiovascular disease (CVD) remains controversial. This study aimed to determine whether PAT is associated with left ventricular (LV) stru
Externí odkaz:
https://doaj.org/article/4e5aadaec738405c8166afc638b79af7
Publikováno v:
Cardiology and Therapy, Vol 9, Iss 2, Pp 219-225 (2020)
Abstract In 2013, canagliflozin was the first sodium–glucose cotransporter 2 inhibitor (SGLT2i) approved by the US Food and Drug Administration for the treatment of type 2 diabetes (T2DM). Today, there are four SGLT2i approved for T2DM, and some SG
Externí odkaz:
https://doaj.org/article/f061f5b9f3984811b39d766582466b0f
Autor:
Sun H. Kim, Fahim Abbasi
Publikováno v:
Endocrinology and Metabolism, Vol 34, Iss 1, Pp 47-52 (2019)
Gerald Reaven was often called the “father of insulin resistance.” On the 1-year anniversary of his death in 2018, we challenge three myths associated with insulin resistance: metformin improves insulin resistance; measurement of waist circumfere
Externí odkaz:
https://doaj.org/article/66bc53c617ba44bd8a5cd971ea43c551
Autor:
Christopher D Gardner, Matthew J Landry, Dalia Perelman, Christina Petlura, Lindsay R Durand, Lucia Aronica, Anthony Crimarco, Kristen M Cunanan, Annie Chang, Christopher C Dant, Jennifer L Robinson, Sun H Kim
Publikováno v:
The American Journal of Clinical Nutrition. 116:640-652
Consensus has not been reached on what constitutes an optimal diet in individuals with prediabetes and type 2 diabetes mellitus (T2DM), especially between low-carbohydrate options.We compared 2 low-carbohydrate diets with 3 key similarities (incorpor
Autor:
Sun H Kim, Ipsa Arora, Daniel S Hsia, William C Knowler, Erin LeBlanc, Eleftherios Mylonakis, Richard Pratley, Anastassios G Pittas
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism.
There is evidence suggesting that infection with SARS-CoV-2 can lead to several long-term sequelae including diabetes. This mini-review examines the rapidly evolving and conflicting literature on new-onset diabetes after COVID-19, which we term NODAC
Autor:
Matthew J. Landry, Anthony Crimarco, Dalia Perelman, Lindsay R. Durand, Christina Petlura, Lucia Aronica, Jennifer L. Robinson, Sun H. Kim, Christopher D. Gardner
Publikováno v:
Nutrients, Vol 13, Iss 3, p 967 (2021)
Adherence is a critical factor to consider when interpreting study results from randomized clinical trials (RCTs) comparing one diet to another, but it is frequently not reported by researchers. The purpose of this secondary analysis of the Keto–Me
Externí odkaz:
https://doaj.org/article/ab51f01969164ce8b5d6dfa039f13e1e
Autor:
Pimsiri Sripongpun, W. Ray Kim, Ajitha Mannalithara, Vivek Charu, Anna Vidovszky, Steven Asch, Manisha Desai, Sun H. Kim, Allison J. Kwong
Publikováno v:
Hepatology. 77:256-267
NAFLD is common in primary care. Liver fibrosis stage 2 or higher (≥F2) increases future risk of morbidity and mortality. We developed and validated a score to aid in the initial assessment of liver fibrosis for NAFLD in primary care.Data from pati
Autor:
Michael Snyder, Fahim Abbasi, Ming-Shian Tsai, Vander Harris, Chelsea S. Harris, Gerald M. Reaven, Joshua W. Knowles, Peter D. Reaven, Sun H. Kim, Fakhar Abbas, Cindy Lamendola, Pragya Tripathi
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 41:2786-2797
Objective: Statin treatment reduces the risk of atherosclerotic cardiovascular disease but is associated with a modest increased risk of type 2 diabetes, especially in those with insulin resistance or prediabetes. Our objective was to determine the p